BIOVERFÜGBARE POLYAMINE

European patent · EP3432914 · In force

Register entry

Publication number
EP3432914
Application number
EP17770923
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 20, 2017
Published
Jan 30, 2019
Granted
Sep 23, 2020
Protection ends at the latest
Mar 19, 2037
Next annual fee due
Mar 31, 2027
IPC classes
A61K 9/20 (2006.01)
A61K 9/28 (2006.01)
A61K 38/45 (2006.01)
A23L 33/00 (2016.01)
A61K 45/06 (2006.01)
A61K 31/78 (2006.01)
Priority
US 201662313657 P 25.03.2016
PCT application
PCT/US2017/023250 20.03.2017
PCT publication
WO2017/165313 28.09.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 9, 2025

    Change

    Published in Swissreg on 09.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. May 27, 2021

    Address changed

    Representative
    Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève → Murgitroyd & Company, 4, Rue du Commerce, 1204 Genève

    Published in Swissreg on 27.05.2021

  6. Dec 18, 2020

    Agent entered

    Representative
    Murgitroyd & Company, 14 Rue du Rhône, 1204 Genève

    Published in Swissreg on 18.12.2020

  7. Sep 23, 2020

    Granted

    Published in Swissreg on 23.09.2020

Parties

Holder

Aminex Therapeutics, Inc.

6947 Coal Creek Pkwy SE No.364, Newcastle, Washington 98059, US

Agent

Murgitroyd & Company

4, Rue du Commerce, 1204 Genève

Inventor

BURNS, Mark, R.

Bothell, WA 98012, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.